Nexalin Technology, Inc. (NXL) Insider Trading & SEC Filings
Last SEC filing
Nexalin Technology, Inc. (NXL) - no SEC Form 4 insider filings recorded in the last 90 days. 4 Form 8-K material event filings were reported by NXL in the last 90 days. InsiderAlpha tracks every NXL SEC filing - Form 4, Form 144, and 8-K - in real time, including Rule 10b5-1 plan detection.
About Nexalin Technology, Inc. (NXL)
Nexalin Technology, Inc. trades under the ticker NXL. InsiderAlpha tracks 17 primary SEC Form 4 filings from 9 reporting insiders for NXL since 2024, sourced directly from SEC EDGAR.
| Sector | Health Care insider trading |
|---|---|
| SIC classification | Electromedical & Electrotherapeutic Apparatus (SIC 3845) |
| SEC CIK | 0001527352 |
90-Day SEC Filing Activity
| Form 8-K filings (90d) | 4 |
|---|---|
| Latest Form 4 filing | 2025-12-23 |
Recent NXL Insider Transactions (Form 4)
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Ben Hu | Director | A - Grant or award | 36.5K | $0.00 | - | SEC | |
| David Owens | Chief Medical Officer | A - Grant or award | 36.5K | $0.00 | - | SEC | |
| Alan Kazden | Director | A - Grant or award | 36.5K | $0.00 | - | SEC | |
| Leonard Osser | 10% Owner | A - Grant or award | 83.3K | $0.00 | - | SEC | |
| David Owens | Chief Medical Officer | P - Open-market purchase | 500 | $2.19 | $1K | SEC | |
| Leslie Bernhard | Director | A - Grant or award | 49.8K | $0.00 | - | SEC | |
| Ben Hu | Director | A - Grant or award | 175.0K | $0.00 | - | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Nexalin Technology, Inc. (NXL). Updated in real time as new filings are submitted to the SEC.
Recent NXL Form 8-K Material Events
- - Item 1.01 [SEC]
- - Item 3.01 [SEC]
- - Item 5.03, 9.01 [SEC]
- - Item 1.01, 3.02, 8.01, 9.01 [SEC]
- - Item 1.01, 7.01, 9.01 · Clinical · positive [SEC]
Nexalin Technology entered into a Scope of Work with Lindus Health Limited to conduct the pivotal clinical trial for its HALO Clarity device, with direct fees of approximately $944,820 plus pass-through expenses. The company announced advancement of this pivotal clinical trial on
Recent Insider Filings
- - Mark White (CEO)
- - Fleet Justin van (CFO)
- - David Owens (Chief Medical Officer)
- - Carolyn Hamby Shelton (Sr. VP - Quality - Regulatory)
- - Ben Hu (Director)
Form 4 Transaction Code Reference
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in NXL insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
NXL Insider Trading - FAQ
- What is the latest insider trade for NXL?
- Nexalin Technology, Inc. (NXL) had 0 insider filings in the last 90 days, with the most recent on 2025-12-23. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
- How many insiders are buying NXL stock?
- 0 insider purchases of NXL were filed in the last 90 days.
- How many insiders are selling NXL stock?
- 0 insider sales of NXL were filed in the last 90 days.
- Where can I see NXL SEC filings (Form 4, 10-K, 10-Q, 8-K)?
- This page tracks NXL Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care Companies with Insider Activity
Other companies in the InsiderAlpha index with a significant SEC Form 4 insider-trading footprint:
- $OBIO Orchestra BioMed Holdings, Inc.
- $ONCO Onconetix, Inc.
- $OPGN CapForce Inc.
- $OSCR Oscar Health, Inc.
- $OTLC Oncotelic Therapeutics, Inc.
- $PEPG PepGen Inc.
- $PHGE BiomX Inc.
- $PLSE PULSE BIOSCIENCES, INC.
- $PMHS Polomar Health Services, Inc.
- $PRCT PROCEPT BioRobotics Corp
Related Companies - Recent Insider Activity
- Axogen, Inc. (AXGN)
- Ceribell, Inc. (CBLL)
- Integer Holdings Corp (ITGR)
- Outset Medical, Inc. (OM)
- Vivani Medical, Inc. (VANI)
- Medtronic plc (MDT)
- CapsoVision, Inc (CV)
- BIOLIFE SOLUTIONS INC (BLFS)
- MASIMO CORP (MASI)
- LivaNova PLC (LIVN)
Learn More
- What is SEC Form 4?
- How to read insider buying signals
- Rule 10b5-1 trading plans explained
- The cluster buying signal
Open the live NXL dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.